These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 33665766)

  • 21. Prevalence and Predictors of Venous Thromboembolism or Mortality in Hospitalized COVID-19 Patients.
    Cohen SL; Gianos E; Barish MA; Chatterjee S; Kohn N; Lesser M; Giannis D; Coppa K; Hirsch JS; McGinn TG; Goldin ME; Spyropoulos AC;
    Thromb Haemost; 2021 Aug; 121(8):1043-1053. PubMed ID: 33472255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control study.
    Ashrani AA; Barsoum MK; Crusan DJ; Petterson TM; Bailey KR; Heit JA
    Thromb Res; 2015 Jun; 135(6):1110-6. PubMed ID: 25891841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Features of Venous Thromboembolism in Patients With Coronavirus Disease 2019 (COVID-19) in Japan　- A Case Series Study.
    Yamashita Y; Hara N; Obana M; Ikeda S; Furuichi M; Ishiguro S; Iwai T; Kobayashi T; Mo M; Yamada N
    Circ J; 2021 Feb; 85(3):309-313. PubMed ID: 33473096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High Prevalence and Mortality Associated with Upper Extremity Deep Venous Thrombosis in Hospitalized Patients at a Tertiary Care Center.
    Rokosh RS; Ranganath N; Yau P; Rockman C; Sadek M; Berland T; Jacobowitz G; Berger J; Maldonado TS
    Ann Vasc Surg; 2020 May; 65():55-65. PubMed ID: 31669473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors.
    Artifoni M; Danic G; Gautier G; Gicquel P; Boutoille D; Raffi F; Néel A; Lecomte R
    J Thromb Thrombolysis; 2020 Jul; 50(1):211-216. PubMed ID: 32451823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study.
    Kearon C; Spencer FA; O'Keeffe D; Parpia S; Schulman S; Baglin T; Stevens SM; Kaatz S; Bauer KA; Douketis JD; Lentz SR; Kessler CM; Moll S; Connors JM; Ginsberg JS; Spadafora L; Julian JA;
    Ann Intern Med; 2015 Jan; 162(1):27-34. PubMed ID: 25560712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study.
    Cohen AT; Katholing A; Rietbrock S; Bamber L; Martinez C
    Thromb Haemost; 2017 Jan; 117(1):57-65. PubMed ID: 27709226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality.
    Violi F; Ceccarelli G; Cangemi R; Cipollone F; D'Ardes D; Oliva A; Pirro M; Rocco M; Alessandri F; D'Ettorre G; Lichtner M; Pignatelli P; Ferro D; Ruberto F; Lip GYH; Pugliese F; Mastroianni CM;
    Intern Emerg Med; 2021 Aug; 16(5):1231-1237. PubMed ID: 34218413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Venous thromboembolism and COVID-19: a case report and review of the literature.
    Bhatt H; Singh S
    J Med Case Rep; 2020 Oct; 14(1):188. PubMed ID: 33054805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 and finding of vein thrombosis: can IMPROVE and IMPROVEDD scores predict COVID-19 outcomes?
    Greco S; Zenunaj G; Bonsi B; Bella A; Lopreiato M; Luciani F; Pedrini D; Vestita G; Dalla Nora E; Passaro A
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):2123-2130. PubMed ID: 33660832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of Risk Factors for Thromboembolic Events in 88 Patients with COVID-19 Pneumonia in Wuhan, China: A Retrospective Descriptive Report.
    Wang W; Sun Q; Bao Y; Liang M; Meng Q; Chen H; Li J; Wang H; Li H; Shi Y; Li Z; Wang X; Zhao S; Wang H; Xiao J; Chen L; Zheng Y; Wang D; Han K
    Med Sci Monit; 2021 Apr; 27():e929708. PubMed ID: 33839733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DVT incidence and risk factors in critically ill patients with COVID-19.
    Chen S; Zhang D; Zheng T; Yu Y; Jiang J
    J Thromb Thrombolysis; 2021 Jan; 51(1):33-39. PubMed ID: 32607652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Venous thromboembolism in COVID-19: A meta-summary of cases.
    ALGhasab NS; Altamimi LA; Alharbi MS; ALMesned SS; Khetan AK
    Saudi Med J; 2022 Sep; 43(9):979-990. PubMed ID: 36104055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term rivaroxaban for the treatment of acute venous thromboembolism in patients with active cancer in a prospective multicenter trial.
    Yhim HY; Choi WI; Kim SH; Nam SH; Kim KH; Mun YC; Oh D; Hwang HG; Lee KW; Song EK; Kwon YS; Bang SM
    Korean J Intern Med; 2019 Sep; 34(5):1125-1135. PubMed ID: 29788694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High Risk of Venous Thromboembolism After Surgery for Long Bone Metastases: A Retrospective Study of 682 Patients.
    Groot OQ; Ogink PT; Janssen SJ; Paulino Pereira NR; Lozano-Calderon S; Raskin K; Hornicek F; Schwab JH
    Clin Orthop Relat Res; 2018 Oct; 476(10):2052-2061. PubMed ID: 30179923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EFFECTS OF SARS COVID-19 POSITIVITY STATUS ON VENOUS THROMBOSIS AND PULMONARY EMBOLISM RATES IN TRAUMA PATIENTS.
    Kenney CL; Nelson AR; Fahey RA; Roubik DJ; How RA; Radowsky JS; Sams VG; Schauer SG; Rizzo JA
    Shock; 2023 Apr; 59(4):599-602. PubMed ID: 36809212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Venous Thromboembolism, Corticosteroids and COVID-19: A Systematic Review and Meta-Analysis.
    Sarfraz A; Sarfraz Z; Razzack AA; Patel G; Sarfraz M
    Clin Appl Thromb Hemost; 2021; 27():1076029621993573. PubMed ID: 33571009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimation of Admission D-dimer Cut-off Value to Predict Venous Thrombotic Events in Hospitalized COVID-19 Patients: Analysis of the SEMI-COVID-19 Registry.
    García-Cervera C; Giner-Galvañ V; Wikman-Jorgensen P; Laureiro J; Rubio-Rivas M; Gurjian Arena A; Arnalich-Fernandez F; Beato Pérez JL; Vargas Núñez JA; González Igual JJ; Díez-Manglano J; Méndez Bailón M; García Blanco MJ; Freire Castro SJ; Aranda Lobo J; Manzano L; Magallanes Gamboa JO; Arribas Pérez L; González Moraleja J; Calderón Hernaiz R; García Alegría J; González Noya A; Gómez Huelgas R; Lumbreras Bermejo C; Antón Santos JM;
    J Gen Intern Med; 2021 Nov; 36(11):3478-3486. PubMed ID: 34287774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors Associated With Risk of Postdischarge Thrombosis in Patients With COVID-19.
    Li P; Zhao W; Kaatz S; Latack K; Schultz L; Poisson L
    JAMA Netw Open; 2021 Nov; 4(11):e2135397. PubMed ID: 34807256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients.
    Obi AT; Tignanelli CJ; Jacobs BN; Arya S; Park PK; Wakefield TW; Henke PK; Napolitano LM
    J Vasc Surg Venous Lymphat Disord; 2019 May; 7(3):317-324. PubMed ID: 30477976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.